Main Article Content
Depression is a debilitating disorder that is associated with many physical, social, and emotional complications. Traditional treatment of depression focuses on altering the neurochemistry of the brain with the use of antidepressant medications. Hovlever, emerging evidence regarding the interaction between the brain and gut microbiome has opened up new avenues for treatment. Probiotics in particular have been studied for their benefits on gastrointestinal health, but recent studies have investigated their role in improving symptoms of depression, emphasizing a link between the gut and the brain. The studies included in this synthesis of evidence demonstrate that probiotics decrease symptoms of depression, which holds promise for novel therapies in treatment of the disorder.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).